NanoEcho declared bankrupt

Stockholm-based healthtech company Encare has signed an agreement with the National Cancer Institute of Thailand (NCI Thailand) to support the implementation of Enhanced Recovery After Surgery (ERAS) in colorectal surgery. The Bangkok institute, which operates under Thailand’s Ministry of Public Health, is Encare’s first hospital partner in the country.

Bergen-based Lifecare has manufactured its first functional continuous glucose monitoring (CGM) implants through its own operations, rather than through an external contract manufacturer. The company calls it an important step toward controlled manufacturing of its implantable sensor technology.

FluoGuide has entered a collaboration with medical technology company Leica Microsystems to advance precision surgery for brain tumors by combining its lead product, FG001, with Leica's surgical microscope systems.

Umeå-based biotech Omnio has raised EUR 2.9 million in an oversubscribed round from existing investors and shareholders. The funding will move the company's plasminogen-based therapy for hard-to-heal chronic wounds closer to clinical trials, with patient studies planned for 2027.

The company has signed a new contract with a leading US hospital network that operates multiple hospitals in the eastern United States. The contract covers an initial installation of 60 next-generation TetraGraph systems for monitoring patients under anaesthesia.

Arjo has presented a new strategy at its Capital Markets Day, committing to improve EBIT by approximately SEK 350 million (±25 million) compared with 2025, by mid-2029.

The company is to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company, provisionally named 'Mölnlycke Surgical', while Wound Care and Antiseptics continue as Mölnlycke.